Publications

Pilar Navarro Medrano

Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation.

Martínez-Bosch N, Fernández-Barrena MG, Moreno M, Ortiz-Zapater E, André S, Gabius H-J, Hwang RF, Poirier F, Munné-Collado J, Iglesias M, Navas C, Guerra C, Fernández-Zapico ME and Navarro P. ,

2014

Key contribution of CPEB4-mediated translational control to cancer progression, Nature Medicine

Ortiz-Zapater E, Pineda D, Martínez-Bosch N, Iglesias M, Alameda F,Moreno M, Eliscovich C, Eyras E, Real FX, Méndez R and Navarro P,

2011

Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer.

Roda O, Ortiz-Zapater E, Martínez-Bosch N, Gutiérrez-Gallego R, Vila-Perelló M, Ampurdanés C, Gabius HJ, André S, Andreu D, Real FX and Navarro P.,

2009

Tissue plasminogen activator induces pancreas cancer cell proliferation by a non-catalytic mechanism that requires ERK1/2 activation through Epidermal Growth Factor Receptor and Annexin A2

Ortiz-Zapater E, Peiro S, Roda O, Corominas JM, Aguilar S, Ampurdanes C, Real FX and Navarro P,

2007

Tissue plasminogen activator mediates amyloid induced neurotoxicity via sustained Erk1/2 activation.

Medina MG, Ledesma, MD, Dominguez JE, Medina M, Zagra D, Alameda F, Dotti CG and Navarro P. ,

2005

The tissue plasminogen activator system in murine exocrine pancreas cancer:selective expression in ductal tumors and contribution to cancer progression.

Aguilar S, Corominas JM, Malats N, Dufresne M, Real FX and Navarro P,

2004

New insights into the tPA-Annexin A2 interaction: is Annexin A2 Cys8 the sole requirement for this association?

Roda O, Valero ML, Peiró S, Andreu D, Real FX and Navarro P,

2003

Publications

You are here

Pilar Navarro Medrano

Pages